현상

제약사 순응

1편 · 2020 1편

Inducing Compliance with Postmarket Studies for Drugs Under FDA’s Accelerated Approval Pathway
MSOM · 2020 · 인용 17 · Liang Xu, Hui Zhao, Nicholas C. Petruzzi